Nevertheless, the lack of FA mutations in 18 HCC does not rule out rare occurrences of proximal FA pathway inactivation in HCC and is consistent with previous reports on the low prevalence of proximal FA pathway inactivation in various tumor entities among the general population [20-22,26,29,68]. This evidence concerns the gene FANCA and hepatocellular carcinoma.